Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Need for Self-sufficient Blood Supply System Stressed Again: Red Cross Symposium
March 19, 2001
- Korosho to Promote Studies to Set Pediatric Doses
March 19, 2001
- Chuikyo Approves 3 New Advanced Medical Technologies
March 19, 2001
- Control Achieved in More than 65% of RA Patients in Long-term Outpatient Care: RDIC Seminar
March 19, 2001
- Notification Issued on ICH Stability Test Guidelines
March 19, 2001
- Significance of Genomic Base Sequence Other than Gene Code Should Be Studied: Prof. Shimizu
March 19, 2001
- REGULATORY NEWS IN BRIEF -1-
March 19, 2001
- PMSB to Issue Notification on Safety Management of Medical Radiation
March 19, 2001
- REGULATORY NEWS IN BRIEF -2-
March 19, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
March 19, 2001
- Number of Elderly Outpatients Decreases Since January: Hodanren Survey
March 19, 2001
- WORLD NEWS IN BRIEF -1-
March 19, 2001
- Kyoritsu College of Pharmacy to Open Pharmacy
March 19, 2001
- WORLD NEWS IN BRIEF -2-
March 19, 2001
- Measures Taken to Prevent Medical Errors Reported: Safety Seminar
March 19, 2001
- Adsorption Type Hemocatharsis Device Designated as Orphan Device
March 19, 2001
- Novartis to Strengthen Presence in Ophthalmic Field
March 19, 2001
- Teijin: New Blood Glucose Self-Monitoring System
March 19, 2001
- BUSINESS NEWS IN BRIEF -1-
March 19, 2001
- Precious Metals for Dental Use to Be Repriced from April 1
March 19, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…